Skip to main content

Table 4 Multivariable logistic regression on polycythemia stratified by smoking status

From: Secondary polycythemia in chronic obstructive pulmonary disease: prevalence and risk factors

Predictive variable

Former smokers (N = 1266)

Current smokers (N = 662)

OR

95% CI

P value

OR

95% CI

P value

Sex, male

4.60

2.29–9.25

 < 0.0001

2.89

1.42–5.91

0.0036

Race, non-Hispanic white

2.96

1.02–8.59

0.046

3.60

1.56–8.30

0.0026

Age at visit (year)

0.98

0.94–1.02

0.34

0.99

0.95–1.04

0.81

Center, Denver

4.22

1.82–9.75

0.0008

5.59

2.16–14.45

0.0004

Body mass index (kg/m2)

1.01

0.95–1.07

0.80

1.05

0.99–1.12

0.079

Pack-years of smoking

0.99

0.98–1.00

0.21

1.00

0.98–1.01

0.71

FEV1% predicted

1.00

0.98–1.02

0.90

0.99

0.96–1.01

0.37

DLCO % predicted

0.97

0.95–0.99

0.0016

0.99

0.97–1.01

0.46

Percent emphysema on CT

0.97

0.94–1.01

0.17

1.01

0.96–1.06

0.81

Resting SpO2

      

 Normal (reference)

1.00

  

1.00

  

 Mild desaturation

0.93

0.45–1.91

0.84

0.98

0.47–2.07

0.96

 Moderate desaturation

0.75

0.27–2.10

0.58

4.00

1.28–12.54

0.017

 Severe desaturation

2.10

0.64–6.87

0.22

8.23

1.93–35.07

0.0044

 Exercise-induced desaturation

1.19

0.60–2.39

0.62

2.66

1.18–6.01

0.019

LTOT use

      

 No use (reference)

1.00

  

1.00

  

  Intermittent

0.70

0.16–3.11

0.64

0.28

0.01–11.96

0.51

 Nocturnal

0.63

0.26–1.53

0.31

0.47

0.12–1.83

0.28

 Continuous

0.24

0.08–0.71

0.0095

0.02

0.00–0.39

0.011

Obstructive sleep apnea

      

 No diagnosis (reference)

1.00

  

1.00

  

 Without CPAP treatment

0.15

0.01–2.40

0.18

0.96

0.25–3.70

0.95

 With CPAP treatment

1.24

0.39–3.95

0.71

0.39

0.08–1.82

0.23

Chronic kidney disease

0.20

0.01–3.29

0.26

0.38

0.02–6.50

0.50

  1. The reported OR and P values are from a single multivariable regression model for each smoking status strata
  2. Bold numbers indicate values with statistical significance P < 0.05
  3. OR odds ratio, CI confidence interval, FEV1 forced expiratory volume in 1 s, DLCO diffusing capacity of lung for carbon monoxide, SpO2 oxyhemoglobin saturation measured by oximetry, LTOT long-term oxygen therapy, CPAP continuous positive airway pressure